India’s Bayer CropScience reports sharp decline in quarterly profit amid rising costs

India’s Bayer CropScience, a subsidiary of German conglomerate Bayer, reported a significant 63.3% decline in its profit for the third quarter. The drop in profits, amounting to a consolidated total of 342 million rupees ($3.9 million), contrasts sharply with the 931 million rupees recorded in the corresponding period the previous year. This financial result covers the three months ending December 31.

Despite a 10.7% increase in revenue from operations, which reached 10.57 billion rupees, the company’s overall expenses surged by 24.9% to approximately 10.56 billion rupees. This substantial rise in costs was the primary driver behind the profit decrease.

The quarterly performance was further impacted by weaker demand growth, attributed to low pest infestations, favorable weather conditions, and delayed seasonal trends which affected overall sales volume.

Looking forward, analysts predict a recovery in India’s agrochemical sector by 2025, following a challenging phase marked by extensive destocking. However, several firms within the sector still face significant hurdles. Peer comparison metrics reveal Bayer CropScience holds a hold rating from analysts, with future estimates suggesting a continuation of revenue growth and an anticipated improvement in profitability.

Source: Reuters